| 1. |
Hayashida H, Masaki K, Ogata H, Yamaguchi T, Tanaka K, Arimura K, Maruoka Y, Kikuchi K, Togao O, Yamasaki R, Isobe N, Focal 18F-fluorodeoxyglucose uptake in spinal dural arteriovenous fistula: A report of two cases, Neurology and Clinical Neuroscience, 2024.01. |
| 2. |
Nagata S, Yamasaki R, Takase EO, Iida K, Watanabe M, Masaki K, Wijering MHC, Yamaguchi H, Kira JI, Isobe N. , Iguratimod Ameliorates the Severity of Secondary Progressive Multiple Sclerosis in Model Mice by Directly Inhibiting IL-6 Production and Th17 Cell Migration via Mitigation of Glial Inflammation., Biology, 2023.09. |
| 3. |
Leppert D, Watanabe M, Schaedelin S, Piehl F, Furlan R, Gastaldi M, Lambert J, Evertsson B, Fink K, Matsushita T, Masaki K, Isobe N, Kira JI, Benkert P, Maceski A, Willemse E, Oechtering J, Orleth A, Meier S, Kuhle J. , Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis., J Neurol Neurosurg Psychiatry, 2023.09. |
| 4. |
Tanaka E, Watanabe M, Fukumoto S, Masaki K, Yamasaki R, Matsushita T, Isobe N. , Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod. , Mult Scler Relat Disord, 2023.02. |
| 5. |
Hashimoto Y, Yamasaki R, Ko S, Matsuo E, Kobayakawa Y, Masaki K, Matsuse D, Isobe N., Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation. , Int J Mol Sci, 2022.12. |
| 6. |
Nishimura Y, Masaki K, Matsuse D, Yamaguchi H, Tanaka T, Matsuo E, Hayashida S, Watanabe M, Matsushita T, Sadashima S, Sasagasako N, Yamasaki R, Isobe N, Iwaki T, Kira JI. , Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy. , Brain Pathol, 10.1111/bpa.13131. , 2022.11. |
| 7. |
Takeuchi H, Masaki K, Ogata H, Nagata S, Shimogawa T, Yamasaki R, Isobe N., Reversible Parkinsonism Caused by Lumboperitoneal Shunt Overdrainage., Neurology, 2022.07. |
| 8. |
Okadome T, Takeuchi H, Yamaguchi T, Mukaino T, Ogata H, Masaki K, Shigeto H, Isobe N. , Shadowboxing-induced reflex seizures in a patient with focal epilepsy., Epilepsy Behav Rep, 2022.04. |
| 9. |
Müller J, Sinnecker T, Wendebourg MJ, Schläger R, Kuhle J, Schädelin S, Benkert P, Derfuss T, Cattin P, Jud C, Spiess F, Amann M, Lincke T, Barakovic M, Cagol A, Tsagkas C, Parmar K, Pröbstel AK, Reimann S, Asseyer S, Duchow A, Brandt A, Ruprecht K, Hadjikhani N, Fukumoto S, Watanabe M, Masaki K, Matsushita T, Isobe N, Kira JI, Kappos L, Würfel J, Granziera C, Paul F, Yaldizli Ö. , Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis., Neurol Neuroimmunol Neuroinflamm, 2022.02. |
| 10. |
Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F; REGAIN Study Group., Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. , Muscle Nerve, 2021.12. |
| 11. |
Miyachi Y, Fujii T, Yamasaki R, Tsuchimoto D, Iinuma K, Sakoda A, Fukumoto S, Matsushita T, Masaki K, Isobe N, Nakabeppu Y, Kira JI., Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay., Front Neurol, 2021.08. |
| 12. |
Une H, Yamasaki R, Nagata S, Yamaguchi H, Nakamuta Y, Indiasari UC, Cui Y, Shinoda K, Masaki K, Götz M, Kira JI., Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination., J Neuroinflammation, 2021.06. |
| 13. |
Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr; REGAIN Study Group. , Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension., Neurology, 2021.01. |
| 14. |
Hayashi F, Isobe N, Glanville J, Matsushita T, Maimaitijiang G, Fukumoto S, Watanabe M, Masaki K, Kira JI. , A new clustering method identifies multiple sclerosis-specific T-cell receptors. , Ann Clin Transl Neurol, 2021.01. |
| 15. |
Watanabe M, Nakamura Y, Sato S, Niino M, Fukaura H, Tanaka M, Ochi H, Kanda T, Takeshita Y, Yokota T, Nishida Y, Matsui M, Nagayama S, Kusunoki S, Miyamoto K, Mizuno M, Kawachi I, Saji E, Ohashi T, Shimohama S, Hisahara S, Nishiyama K, Iizuka T, Nakatsuji Y, Okuno T, Ochi K, Suzumura A, Yamamoto K, Kawano Y, Tsuji S, Hirata M, Sakate R, Kimura T, Shimizu Y, Nagaishi A, Okada K, Hayashi F, Sakoda A, Masaki K, Shinoda K, Isobe N, Matsushita T, Kira JI. , HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data., Sci Rep, 2021.01. |
| 16. |
Richard C, Ruiz A, Cavagna S, Bigotte M, Vukusic S, Masaki K, Suenaga T, Kira JI, Giraudon P, Marignier R. , Connexins in neuromyelitis optica: a link between astrocytopathy and demyelination, Brain, 2020.09. |
| 17. |
Hayashida S, Masaki K, Suzuki SO, Yamasaki R, Watanabe M, Koyama S, Isobe N, Matsushita T, Takahashi K, Tabira T, Iwaki T, Kira JI. , Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders, Brain Pathol, 2020.09. |
| 18. |
Matsuse D, Yamasaki R, Maimaitijiang G, Yamaguchi H, Masaki K, Isobe N, Matsushita T, Kira JI. , Early decrease in intermediate monocytes in peripheral blood is characteristic of multiple system atrophy-cerebellar type, J Neuroimmunol, 2020.09. |
| 19. |
Matsushita T, Masaki K, Isobe N, Sato S, Yamamoto K, Nakamura Y, Watanabe M, Suenaga T, Kira JI; Japan Multiple Sclerosis Genetic Consortium., Genetic factors for susceptibility to and manifestations of neuromyelitis optica, Ann Clin Transl Neurol, 2020.09. |
| 20. |
Torii Y, Iritani S, Sekiguchi H, Habuchi C, Fujishiro H, Kushima I, Kawakami I, Itokawa M, Arai M, Hayashida S, Masaki K, Kira JI, Kawashima K, Ozaki N., The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study, Schizophr Res, 2020.09. |
| 21. |
Torii Y, Iritani S, Marui T, Sekiguchi H, Habuchi C, Fujishiro H, Kushima I, Oshima K, Niizato K, Hayashida S, Masaki K, Kira JI, Yoshida M, Ozaki N. , Morphological alteration of myelin-oligodendrocytes in a schizophrenic patient with 22q11.2 deletion syndrome: An autopsy study, Schizophr Res., 2020.07. |
| 22. |
Shinoda K, Matsushita T, Nakamura Y, Masaki K, Sakai S, Nomiyama H, Togao O, Hiwatashi A, Niino M, Isobe N, Kira JI., Contribution of Cortical Lesions to Cognitive Impairment in Japanese Patients With Multiple Sclerosis, Sci Rep, 2020.03. |
| 23. |
Masaki K, Sonobe Y, Ghadge G, Pytel P, Lépine P, Pernin F, Cui QL, Antel JP, Zandee S, Prat A, Roos RP., RNA-binding Protein Altered Expression and Mislocalization in MS, Neurol Neuroimmunol Neuroinflamm, 2020.03. |
| 24. |
Zhao Y, Yamasaki R, Yamaguchi H, Nagata S, Une H, Cui Y, Masaki K, Nakamuta Y, Iinuma K, Watanabe M, Matsushita T, Isobe N, Kira JI., Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis., Proc Natl Acad Sci U S A, 2020.01. |
| 25. |
Sakoda A, Matsushita T, Nakamura Y, Watanabe M, Shinoda K, Masaki K, Isobe N, Yamasaki R, Kira JI., Environmental risk factors for multiple sclerosis in Japanese people., Mult Scler Relat Disord. , 2019.11. |
| 26. |
Maimaitijiang G, Watanabe M, Shinoda K, Isobe N, Nakamura Y, Masaki K, Matsushita T, Yoshikai Y, Kira JI., Long-term use of interferon-β in multiple sclerosis increases Vδ1-Vδ2-Vγ9- γδ T cells that are associated with a better outcome., J Neuroinflammation, 2019.09. |
| 27. |
Zhang X, Fujii T, Ogata H, Yamasaki R, Masaki K, Cui Y, Matsushita T, Isobe N, Kira JI., Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis., J Neuroimmunol. , 2019.05. |
| 28. |
Masaki K, Sonobe Y, Ghadge G, Pytel P, Roos RP., TDP-43 proteinopathy in Theiler's murine encephalomyelitis virus infection., PLoS Pathogens, 2019.02. |
| 29. |
Cui Y, Masaki K, Zhang X, Yamasaki R, Fujii T, Ogata H, Hayashida S, Yamaguchi H, Hyodo F, Eto H, Koyama S, Iinuma K, Yonekawa T, Matsushita T, Yoshida M, Yamada K, Kawano M, Malissen M, Malissen B, Kira J., A novel model for treatment of hypertrophic pachymeningitis., Ann Clin Transl Neurol, 2019.01. |
| 30. |
Kobayakawa Y, Masaki K, Yamasaki R, Shiraishi W, Hayashida S, Hayashi S, Okamoto K, Matsushita T, Kira JI., Downregulation of Neuronal and Dendritic Connexin36-Made Electrical Synapses Without Glutamatergic Axon Terminals in Spinal Anterior Horn Cells From the Early Stage of Amyotrophic Lateral Sclerosis., Front Neurosci., 2018.11. |
| 31. |
Fang M, Yamasaki R, Li G, Masaki K, Yamaguchi H, Fujita A, Isobe N, Kira JI., Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia., Front Immunol., 2018.11. |
| 32. |
Sonobe Y, Ghadge G, Masaki K, Sendoel A, Fuchs E, Roos RP., Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress., Neurobiol Dis., 2018.08. |
| 33. |
Marui T, Torii Y, Iritani S, Sekiguchi H, Habuchi C, Fujishiro H, Oshima K, Niizato K, Hayashida S, Masaki K, Kira J, Ozaki N., The neuropathological study of myelin oligodendrocyte glycoprotein in the temporal lobe of schizophrenia patients., Acta Neuropsychiatr., 2018.08. |
| 34. |
Shinoda K, Matsushita T, Nakamura Y, Masaki K, Yamasaki R, Yamaguchi H, Togao O, Hiwatashi A, Kira JI., HLA-DRB1*04:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis., Mult Scler., 2018.05. |
| 35. |
Maimaitijiang G, Shinoda K, Nakamura Y, Masaki K, Matsushita T, Isobe N, Yamasaki R, Yoshikai Y, Kira JI., Association of Decreased Percentage of Vδ2+Vγ9+ γδ T Cells With Disease Severity in Multiple Sclerosis., Front Immunol., 2018.04. |
| 36. |
Li G, Yamasaki R, Fang M, Masaki K, Ochi H, Matsushita T, Kira JI., Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway., Sci Rep., 2018.01. |
| 37. |
Hayashida S, Masaki K, Yonekawa T, Suzuki SO, Hiwatashi A, Matsushita T, Watanabe M, Yamasaki R, Suenaga T, Iwaki T, Murai H, Kira JI., Early and extensive spinal white matter involvement in neuromyelitis optica., Brain Pathol. , 2017.05. |
| 38. |
Watanabe M, Masaki K, Yamasaki R, Kawanokuchi J, Takeuchi H, Matsushita T, Suzumura A, Kira JI., Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation., Sci Rep. , 2016.12. |
| 39. |
Yamasaki R, Fujii T, Wang B, Masaki K, Kido MA, Yoshida M, Matsushita T, Kira JI., Allergic Inflammation Leads to Neuropathic Pain via Glial Cell Activation., J Neurosci., 2016.11. |
| 40. |
Ramanathan S, Sato S, Matsushita T, Masaki K, Yamasaki R, Dale RC, Kira J, Brilot F., Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis., Mult Scler. , 2016.01. |
| 41. |
Sato S, Yamamoto K, Matsushita T, Isobe N, Kawano Y, Iinuma K, Niino M, Fukazawa T, Nakamura Y, Watanabe M, Yonekawa T, Masaki K, Yoshimura S, Murai H, Yamasaki R, Kira J; Japan Multiple Sclerosis Genetics Consortium., Copy number variations in multiple sclerosis and neuromyelitis optica., Ann Neurol. , 2015.11. |
| 42. |
Song ZY, Yamasaki R, Kawano Y, Sato S, Masaki K, Yoshimura S, Matsuse D, Murai H, Matsushita T, Kira J., Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod., PLoS One, 2015.04. |
| 43. |
Niino M, Sato S, Fukazawa T, Masaki K, Miyazaki Y, Matsuse D, Yamasaki R, Takahashi E, Kikuchi S, Kira J., Decreased serum vitamin D levels in Japanese patients with multiple sclerosis., J Neuroimmunol., 2015.02. |
| 44. |
Yonekawa T, Murai H, Utsuki S, Matsushita T, Masaki K, Isobe N, Yamasaki R, Yoshida M, Kusunoki S, Sakata K, Fujii K, Kira J., A nationwide survey of hypertrophic pachymeningitis in Japan., J Neurol Neurosurg Psychiatry. , 2014.07. |
| 45. |
Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, Ochi H, Kira J., Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients., PLoS One, 2014.04. |
| 46. |
Cui Y, Masaki K, Yamasaki R, Imamura S, Suzuki SO, Hayashi S, Sato S, Nagara Y, Kawamura MF, Kira J., Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model., J Neuroinflammation, 10.1186/1742-2094-11-42., 6, 11, 42, 2014.03. |
| 47. |
Masaki K, Suzuki SO, Matsushita T, Matsuoka T, Imamura S, Yamasaki R, Suzuki M, Suenaga T, Iwaki T, Kira J., Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica., PLOS ONE, e72919, 2013.08. |
| 48. |
Suzuki M, Kawasaki H, Masaki K, Suzuki SO, Terada T, Tsuchida T, Tokuyama T, Kono S, Komori T, Baba S, Kira J, Miyajima H., An autopsy case of the Marburg variant of multiple sclerosis (acute multiple sclerosis)., Intern Med., 2013.06. |
| 49. |
Isobe N, Yonekawa T, Matsushita T, Masaki K, Yoshimura S, Fichna J, Chen S, Furmaniak J, Smith BR, Kira J., Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica., Neurochem Res. , 2013.05. |
| 50. |
Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, Kawano Y, Kira J; South Japan Multiple Sclerosis Genetics Consortium., Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status., J Neurol Neurosurg Psychiatry. , 2013.01. |
| 51. |
Isobe N, Yonekawa T, Matsushita T, Kawano Y, Masaki K, Yoshimura S, Fichna J, Chen S, Furmaniak J, Smith BR, Kira J., Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica., Mult Scler. , 2012.11. |
| 52. |
Sato S, Isobe N, Yoshimura S, Kanamori Y, Masaki K, Matsushita T, Kira J., HLA-DPB1*0201 is associated with susceptibility to atopic myelitis in Japanese., J Neuroimmunol. , 2012.10. |
| 53. |
Masaki K, Suzuki SO, Matsushita T, Yonekawa T, Matsuoka T, Isobe N, Motomura K, Wu XM, Tabira T, Iwaki T, Kira J., Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction., Acta Neuropathologica, 123, 887-900, 2012.06. |
| 54. |
Yoshimura S, Isobe N, Yonekawa T, Matsushita T, Masaki K, Sato S, Kawano Y, Yamamoto K, Kira J; South Japan Multiple Sclerosis Genetics Consortium., Genetic and infectious profiles of Japanese multiple sclerosis patients., PLoS One. , 2012.06. |
| 55. |
Estiasari R, Matsushita T, Masaki K, Akiyama T, Yonekawa T, Isobe N, Kira J., Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjogren's syndrome patients with central nervous system manifestations., Mult Scler. , 2012.06. |
| 56. |
Ainiding G, Yamashita K, Torii T, Furuta K, Isobe N, Matsushita T, Masaki K, Matsumoto S, Kira J., Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis., J Neuroimmunol. , 2012.05. |
| 57. |
Fang L, Isobe N, Yoshimura S, Yonekawa T, Matsushita T, Masaki K, Doi H, Ochi K, Miyamoto K, Kawano Y, Kira J; South Japan Multiple Sclerosis Genetics Consortium., Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians., Neurology, 2011.06. |
| 58. |
Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H, Masaki K, Yoshiura T, Yamasaki R, Ohyagi Y, Kira J., Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status., J Neurol Sci. , 2010.04. |
| 59. |
Li W, Minohara M, Piao H, Matsushita T, Masaki K, Matsuoka T, Isobe N, Su JJ, Ohyagi Y, Kira J., Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica., Mult Scler., 2009.12. |
